Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. (NASDAQ: HSIC) generates a steady flow of news as a FORTUNE 500 and S&P 500® health care solutions company serving office-based dental and medical practitioners. As a medical, dental, and hospital equipment and supplies merchant wholesaler with a significant technology footprint, the company issues updates that cover financial performance, leadership changes, partnerships, and product and technology developments.
Investors following HSIC news will find regular earnings and guidance announcements, including quarterly financial results and updates on sales growth across its Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. These releases often highlight trends in dental and medical distribution, specialty dental products, and technology adoption, as well as commentary on strategic initiatives such as the company’s BOLD+1 strategy and value creation programs.
Henry Schein news also includes leadership and governance updates, such as the announced retirement of long-time CEO Stanley M. Bergman from the chief executive role and the appointment of Frederick M. Lowery as the company’s next CEO, effective March 2, 2026. These items provide insight into succession planning and the company’s approach to long-term leadership continuity.
Another key theme in HSIC coverage is technology and innovation in dental practice management. Through Henry Schein One, the company reports on new AI-enabled workflows, embedded automation, and collaborations with partners like Amazon Web Services and VideaHealth. News items describe developments in practice management platforms such as Dentrix and Dentrix Ascend, including AI-driven documentation, imaging, and revenue cycle tools.
In addition, Henry Schein announces strategic partnerships and distribution agreements, such as its expanded relationship with vVARDIS for the Curodont Repair Fluoride Plus product across U.S. dental segments. These stories shed light on how the company broadens its product offerings and supports dental professionals with new clinical options.
For investors, analysts, and health care professionals, the HSIC news feed on Stock Titan offers a centralized view of these corporate developments, helping users monitor how Henry Schein’s distribution, specialty products, and technology initiatives evolve over time.
Henry Schein (Nasdaq: HSIC), a leading health care solutions provider, will announce its Q1 2021 financial results on May 4, 2021, before market opening. A live webcast of the earnings conference call will be held at 10:00 a.m. Eastern Time, featuring Stanley M. Bergman and Steven Paladino. Investors can access the call via www.henryschein.com/IRwebcasts. In 2020, Henry Schein reported sales of $10.1 billion, highlighting strong growth since going public in 1995.
Henry Schein (Nasdaq: HSIC) has acquired a majority stake in Stradis Medical, enhancing its commitment to the growing ambulatory surgery market. Stradis Healthcare specializes in medical device packaging and custom procedure kits, generating approximately $39 million in sales over the past year. The deal aims to combine product offerings, improve operational efficiencies, and create new business opportunities. While the acquisition will be neutral to HSIC’s 2021 earnings per share, it is expected to be accretive thereafter. CEO Stanley Bergman highlights the strategic importance of this partnership.
Henry Schein (Nasdaq: HSIC) announced a partnership with the Black Coalition Against COVID-19 (BCAC) to support vaccine equity via the virtual town hall series, "Making It Plain." This initiative emphasizes the essential role of primary-care physicians in increasing COVID-19 vaccination accessibility, especially in minority communities. CEO Stanley M. Bergman highlighted the importance of engaging trusted healthcare providers to ensure broader vaccine distribution. The partnership aims to create additional vaccination sites across the U.S., promoting equitable access to the COVID-19 vaccine.
Henry Schein, Inc. (Nasdaq: HSIC) CEO Stanley M. Bergman supports a Congressional effort to include primary-care physicians and dentists in the national COVID-19 vaccination strategy. He highlights the importance of these trusted community figures in overcoming vaccine hesitancy, especially in underserved communities. The company commends recent amendments to the Public Readiness and Emergency Preparedness Act, expanding the pool of qualified vaccinators. With over 19,000 employees and a presence in 31 countries, Henry Schein continues to prioritize health equity while offering over 300 solutions for healthcare professionals.
The Henry Schein Cares Foundation has launched the second phase of its ‘Wearing is Caring’ campaign, aimed at improving awareness of the link between oral health and overall wellness. In partnership with The UPS Foundation, funding is directed towards the Special Olympics Healthy Athletes® programs in Louisiana, Georgia, and Mississippi, which provide crucial health screenings for athletes. The program showed significant improvements in oral health, with 67% of participants reporting no mouth pain and 25% reporting no untreated decay after care.
Henry Schein, the largest health care solutions provider for dental and medical practitioners, announced amendments to its private placement facility agreements to reinstate its share repurchase program. With $201 million authorized for future stock repurchases, this move reflects the company's ongoing commitment to increasing shareholder value. CEO Stanley M. Bergman emphasized that strong cash flow allows continued investment in strategic acquisitions and share repurchases, enhancing returns on capital.
Summary not available.
Grin has announced a partnership with Henry Schein Orthodontics to offer the Grin Remote Monitoring and Remote Consultation platforms to orthodontic practices across the U.S. This collaboration aims to streamline initial consultations, significantly reducing costs associated with patient acquisition, which can range from $900 to $1,350. The Grin Scope device, coupled with the Grin App, enables patients to self-scan their teeth, providing orthodontists with detailed videos for analysis. This innovative approach addresses the demand for convenience and safety in orthodontic care.
Henry Schein (Nasdaq: HSIC) has been recognized by Ethisphere as one of the 2021 World’s Most Ethical Companies, marking its 10th consecutive year as a honoree and the only recognition in the Healthcare Products industry. With over 19,000 Team Schein Members, the company emphasizes ethical practices as foundational to its success. Ethisphere's Ethics Index indicates honorees outperformed a comparable index by 7.1 percentage points from January 2016 to January 2021. Henry Schein operates in 31 countries, providing solutions to over 1 million customers with $10.1 billion in sales in 2020.
Henry Schein (Nasdaq: HSIC), the largest provider of health care solutions, will present virtually at the 2021 Barclays Global Healthcare Conference on March 9, 2021, at 2:25 p.m. Eastern time. Interested parties can access the live webcast at www.henryschein.com/IRwebcasts. A replay will be available afterward. With over 19,000 Team Schein Members, Henry Schein serves more than 1 million customers globally, delivering 300+ solutions to improve efficiency and clinical outcomes in the dental and medical sectors.